Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905148-05-004622
Filing Date
2005-09-09
Accepted
2005-09-09 17:01:14
Documents
1
Group Members
GLENVIEW CAPITAL GP, LLCGLENVIEW CAPITAL MANAGEMENT, LLCLAWRENCE M ROBBINS

Document Format Files

Seq Description Document Type Size
1 efc5-1929_5759714formsc13g.txt SC 13G 18321
  Complete submission text file 0000905148-05-004622.txt   20408
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43329 | Film No.: 051078286
SIC: 2834 Pharmaceutical Preparations

Mailing Address 399 PARK AVENUE FLOOR 39 NEW YORK NY 10022
Business Address 399 PARK AVENUE FLOOR 39 NEW YORK NY 10022 2128124700
GLENVIEW CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001138995 (see all company filings)

EIN.: 134136746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G